Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2013

01.06.2013 | Research Paper

Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions

verfasst von: Jong Hoon Lee, Joo Hwan Lee, Hong Seok Jang, Hyo Chun Lee, Jung Won Lee, Dae Gyu Kang, Byoung Yong Shim, Bong-Hyeon Kye, Hyung Jin Kim, Hyeon-Min Cho, Young Jin Suh, Sung Hwan Kim

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the efficacy and toxicity for patients with hepatic oligometastases, receiving hypofractionated radiotherapy with Tomotherapy to the liver. A total of 42 patients with 54 hepatic lesions, who had been treated from 2007 to 2011 at two institutions, were retrospectively reviewed for this study. All the patients received radical resections of the primary tumor, and had been presented with one to two hepatic lesions. The radiation dose of 40–75 Gy in 10–20 fractions (median, 50 Gy in 10 fractions) was delivered for the planning target volume. At a median follow-up time of 15 months, 1- and 2-year local control (LC) rates were 59.9 and 49.0 %, respectively. The 1- and 2-year overall survival (OS) rates were 60.0 and 44.0 %, respectively. Maximal tumor diameter of <3 cm and biologically effective dose (BED) of ≥100 Gyα/β=10 were significantly associated with higher LC and OS. Primary colorectal cancer tended to be associated with higher LC (P = 0.075), and was significantly associated with higher OS (P = 0.037). 12 (28.6 %) of the 42 patients had grade 1–2 toxicities, and grade 3 or higher toxicity did not occur. Hypofractionated radiotherapy with Tomotherapy was safe for patients with hepatic oligometastases. The maximal tumor diameter of <3 cm and BED of ≥100 Gyα/β=10 were significant prognostic factors for higher local control and survival, and primary colorectal cancer patients had statistically higher overall survival than the others.
Literatur
1.
Zurück zum Zitat Niibe Y, Hayakawa K (2010) Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 40(2):107–111PubMedCrossRef Niibe Y, Hayakawa K (2010) Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 40(2):107–111PubMedCrossRef
2.
Zurück zum Zitat Buscarini E, Savoia A, Brambilla G et al (2005) Radiofrequency thermal ablation of liver tumors. Eur Radiol 15(5):884–894PubMedCrossRef Buscarini E, Savoia A, Brambilla G et al (2005) Radiofrequency thermal ablation of liver tumors. Eur Radiol 15(5):884–894PubMedCrossRef
3.
Zurück zum Zitat Shibata T, Niinobu T, Ogata N et al (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89(2):276–284PubMedCrossRef Shibata T, Niinobu T, Ogata N et al (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89(2):276–284PubMedCrossRef
4.
Zurück zum Zitat Topkan E, Onal HC, Yavuz MN (2008) Managing liver metastases with conformal radiation therapy. J Support Oncol 6(1):9–13PubMed Topkan E, Onal HC, Yavuz MN (2008) Managing liver metastases with conformal radiation therapy. J Support Oncol 6(1):9–13PubMed
5.
Zurück zum Zitat Kang JK, Kim MS, Kim JH et al (2010) Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 27(4):273–278PubMedCrossRef Kang JK, Kim MS, Kim JH et al (2010) Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 27(4):273–278PubMedCrossRef
6.
Zurück zum Zitat Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578PubMedCrossRef Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) Multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578PubMedCrossRef
7.
Zurück zum Zitat Heron DE, Gerszten K, Selvaraj RN et al (2003) Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose–volume histograms small star, filled. Gynecol Oncol 91(1):39–45PubMedCrossRef Heron DE, Gerszten K, Selvaraj RN et al (2003) Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose–volume histograms small star, filled. Gynecol Oncol 91(1):39–45PubMedCrossRef
8.
Zurück zum Zitat Wulf J, Guckenberger M, Haedinger U et al (2006) Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45(7):838–847PubMedCrossRef Wulf J, Guckenberger M, Haedinger U et al (2006) Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45(7):838–847PubMedCrossRef
9.
Zurück zum Zitat Decoster L, Schallier D, Everaert H et al (2008) Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). Lung Cancer 62(1):55–61PubMedCrossRef Decoster L, Schallier D, Everaert H et al (2008) Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). Lung Cancer 62(1):55–61PubMedCrossRef
10.
Zurück zum Zitat Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10PubMed Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10PubMed
11.
Zurück zum Zitat McCammon R, Schefter TE, Gaspar LE et al (2009) Observation of a dose–control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73(1):112–118PubMedCrossRef McCammon R, Schefter TE, Gaspar LE et al (2009) Observation of a dose–control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73(1):112–118PubMedCrossRef
12.
Zurück zum Zitat Onishi H, Araki T, Shirato H et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7):1623–1631PubMedCrossRef Onishi H, Araki T, Shirato H et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7):1623–1631PubMedCrossRef
13.
Zurück zum Zitat Lee JH, Kim SH, Kim JG et al (2011) Preoperative Chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 81(2):431–438PubMedCrossRef Lee JH, Kim SH, Kim JG et al (2011) Preoperative Chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 81(2):431–438PubMedCrossRef
14.
Zurück zum Zitat Jung KW, Park S, Kong HJ et al (2011) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 44(1):11–24CrossRef Jung KW, Park S, Kong HJ et al (2011) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 44(1):11–24CrossRef
15.
Zurück zum Zitat Lee JH, Jang HS, Kim JG et al (2012) Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol 19(4):1213–1221PubMedCrossRef Lee JH, Jang HS, Kim JG et al (2012) Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol 19(4):1213–1221PubMedCrossRef
16.
Zurück zum Zitat Lee JH, Kim DY, Nam TK et al (2012) Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01). Int J Radiat Oncol Biol Phys 84(4):955–961PubMedCrossRef Lee JH, Kim DY, Nam TK et al (2012) Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01). Int J Radiat Oncol Biol Phys 84(4):955–961PubMedCrossRef
17.
Zurück zum Zitat Aloia TA, Vauthey JN, Loyer EM et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141(5):460–466PubMedCrossRef Aloia TA, Vauthey JN, Loyer EM et al (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141(5):460–466PubMedCrossRef
18.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77(7):1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77(7):1254–1262PubMedCrossRef
19.
Zurück zum Zitat Scheele J, Stangl R, Altendorf-Hofmann A et al (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110(1):13–29PubMed Scheele J, Stangl R, Altendorf-Hofmann A et al (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110(1):13–29PubMed
20.
Zurück zum Zitat De Leyn P, Stroobants S, De Wever W et al (2006) Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: a Leuven lung cancer group study. J Clin Oncol 24(21):3333–3339PubMedCrossRef De Leyn P, Stroobants S, De Wever W et al (2006) Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer: a Leuven lung cancer group study. J Clin Oncol 24(21):3333–3339PubMedCrossRef
21.
Zurück zum Zitat Lubezky N, Metser U, Geva R et al (2007) The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11(4):472–478PubMedCrossRef Lubezky N, Metser U, Geva R et al (2007) The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11(4):472–478PubMedCrossRef
22.
Zurück zum Zitat Van den Eynden GG, Bird NC, Majeed AW et al (2012) The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29(6):541–549PubMedCrossRef Van den Eynden GG, Bird NC, Majeed AW et al (2012) The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29(6):541–549PubMedCrossRef
Metadaten
Titel
Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions
verfasst von
Jong Hoon Lee
Joo Hwan Lee
Hong Seok Jang
Hyo Chun Lee
Jung Won Lee
Dae Gyu Kang
Byoung Yong Shim
Bong-Hyeon Kye
Hyung Jin Kim
Hyeon-Min Cho
Young Jin Suh
Sung Hwan Kim
Publikationsdatum
01.06.2013
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2013
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-013-9568-7

Weitere Artikel der Ausgabe 5/2013

Clinical & Experimental Metastasis 5/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.